UA55454C2 - Способ лечения воспалительных и воспалительно-деструктивных процессов в пародонте - Google Patents
Способ лечения воспалительных и воспалительно-деструктивных процессов в пародонте Download PDFInfo
- Publication number
- UA55454C2 UA55454C2 UA99126560A UA99126560A UA55454C2 UA 55454 C2 UA55454 C2 UA 55454C2 UA 99126560 A UA99126560 A UA 99126560A UA 99126560 A UA99126560 A UA 99126560A UA 55454 C2 UA55454 C2 UA 55454C2
- Authority
- UA
- Ukraine
- Prior art keywords
- inflammatory
- lipin
- treatment
- drug
- destructive processes
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 33
- 230000008569 process Effects 0.000 title claims abstract description 13
- 230000002757 inflammatory effect Effects 0.000 title claims abstract description 10
- 239000012188 paraffin wax Substances 0.000 claims abstract description 8
- 235000018553 tannin Nutrition 0.000 claims abstract description 6
- 229920001864 tannin Polymers 0.000 claims abstract description 6
- 239000001648 tannin Substances 0.000 claims abstract description 6
- 235000019155 vitamin A Nutrition 0.000 claims abstract description 6
- 239000011719 vitamin A Substances 0.000 claims abstract description 6
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 6
- 239000011709 vitamin E Substances 0.000 claims abstract description 6
- 239000000725 suspension Substances 0.000 claims abstract description 5
- 239000003814 drug Substances 0.000 claims description 22
- 229940079593 drug Drugs 0.000 claims description 21
- 239000000243 solution Substances 0.000 claims description 18
- 208000005888 Periodontal Pocket Diseases 0.000 claims description 11
- 239000007924 injection Substances 0.000 claims description 10
- 238000002347 injection Methods 0.000 claims description 10
- 210000004261 periodontium Anatomy 0.000 claims description 8
- 239000000843 powder Substances 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 4
- 210000004400 mucous membrane Anatomy 0.000 abstract description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 abstract 1
- 210000001519 tissue Anatomy 0.000 description 13
- 230000002421 anti-septic effect Effects 0.000 description 9
- 230000000740 bleeding effect Effects 0.000 description 7
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 208000008887 Dental Deposits Diseases 0.000 description 5
- 210000000214 mouth Anatomy 0.000 description 5
- 208000002193 Pain Diseases 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 230000001575 pathological effect Effects 0.000 description 4
- 230000003239 periodontal effect Effects 0.000 description 4
- 206010006326 Breath odour Diseases 0.000 description 3
- 208000003433 Gingival Pocket Diseases 0.000 description 3
- OJMMVQQUTAEWLP-UHFFFAOYSA-N Lincomycin Natural products CN1CC(CCC)CC1C(=O)NC(C(C)O)C1C(O)C(O)C(O)C(SC)O1 OJMMVQQUTAEWLP-UHFFFAOYSA-N 0.000 description 3
- 206010068546 Traumatic occlusion Diseases 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 230000000843 anti-fungal effect Effects 0.000 description 3
- 230000000842 anti-protozoal effect Effects 0.000 description 3
- 229940121375 antifungal agent Drugs 0.000 description 3
- 239000003904 antiprotozoal agent Substances 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 239000007927 intramuscular injection Substances 0.000 description 3
- 238000010255 intramuscular injection Methods 0.000 description 3
- OJMMVQQUTAEWLP-KIDUDLJLSA-N lincomycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@@H](C)O)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 OJMMVQQUTAEWLP-KIDUDLJLSA-N 0.000 description 3
- 229960005287 lincomycin Drugs 0.000 description 3
- IAIWVQXQOWNYOU-FPYGCLRLSA-N nitrofural Chemical compound NC(=O)N\N=C\C1=CC=C([N+]([O-])=O)O1 IAIWVQXQOWNYOU-FPYGCLRLSA-N 0.000 description 3
- 229960001907 nitrofurazone Drugs 0.000 description 3
- 201000001245 periodontitis Diseases 0.000 description 3
- 230000003501 anti-edematous effect Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000001680 brushing effect Effects 0.000 description 2
- 210000002808 connective tissue Anatomy 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 210000000981 epithelium Anatomy 0.000 description 2
- 210000000416 exudates and transudate Anatomy 0.000 description 2
- 230000005714 functional activity Effects 0.000 description 2
- 201000005562 gingival recession Diseases 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 230000003859 lipid peroxidation Effects 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 230000029058 respiratory gaseous exchange Effects 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- FUBFWTUFPGFHOJ-UHFFFAOYSA-N 2-nitrofuran Chemical class [O-][N+](=O)C1=CC=CO1 FUBFWTUFPGFHOJ-UHFFFAOYSA-N 0.000 description 1
- 206010001367 Adrenal insufficiency Diseases 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 208000006558 Dental Calculus Diseases 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010028347 Muscle twitching Diseases 0.000 description 1
- 208000037273 Pathologic Processes Diseases 0.000 description 1
- 206010072574 Periodontal inflammation Diseases 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- DOIGHQCAQBRSKI-UHFFFAOYSA-N [3-(hydroxymethyl)-1-oxido-4-oxoquinoxalin-4-ium-2-yl]methanol Chemical compound C1=CC=C2N([O-])C(CO)=C(CO)[N+](=O)C2=C1 DOIGHQCAQBRSKI-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 208000017515 adrenocortical insufficiency Diseases 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000141 anti-hypoxic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 229940064004 antiseptic throat preparations Drugs 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000010835 comparative analysis Methods 0.000 description 1
- 230000002920 convulsive effect Effects 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 230000001779 embryotoxic effect Effects 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 230000003511 endothelial effect Effects 0.000 description 1
- 230000005713 exacerbation Effects 0.000 description 1
- 210000004195 gingiva Anatomy 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 235000021268 hot food Nutrition 0.000 description 1
- 239000002955 immunomodulating agent Substances 0.000 description 1
- 230000002584 immunomodulator Effects 0.000 description 1
- 229940121354 immunomodulator Drugs 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000002262 irrigation Effects 0.000 description 1
- 238000003973 irrigation Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 230000006651 lactation Effects 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 244000005706 microflora Species 0.000 description 1
- 231100000219 mutagenic Toxicity 0.000 description 1
- 230000003505 mutagenic effect Effects 0.000 description 1
- 210000003739 neck Anatomy 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000009054 pathological process Effects 0.000 description 1
- 238000000053 physical method Methods 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 239000002594 sorbent Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000008174 sterile solution Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 231100000378 teratogenic Toxicity 0.000 description 1
- 230000003390 teratogenic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Dental Preparations (AREA)
Abstract
Изобретение относится к стоматологии, в частности к способу лечения воспалительных и воспалительно-деструктивных процессов в пародонте. Проводят внутрислизистые инъекции 10%-ной суспензии липина в физиологическом растворе по 1 мл в переходные складки верхней и нижней челюсти, а затем в пародонтальные карманы вводят лечебную пасту, состоящую из смеси порошков липина и танина в соотношении 1:1 и 0,1 мл масляного раствора витаминов А и Е на 2-3 часа под затвердевающую повязку парафина.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UA99126560A UA55454C2 (ru) | 1999-12-02 | 1999-12-02 | Способ лечения воспалительных и воспалительно-деструктивных процессов в пародонте |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UA99126560A UA55454C2 (ru) | 1999-12-02 | 1999-12-02 | Способ лечения воспалительных и воспалительно-деструктивных процессов в пародонте |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA55454C2 true UA55454C2 (ru) | 2003-04-15 |
Family
ID=74206823
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UA99126560A UA55454C2 (ru) | 1999-12-02 | 1999-12-02 | Способ лечения воспалительных и воспалительно-деструктивных процессов в пародонте |
Country Status (1)
| Country | Link |
|---|---|
| UA (1) | UA55454C2 (ru) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2708615C1 (ru) * | 2019-10-02 | 2019-12-10 | Федеральное государственное автономное образовательное учреждение высшего образования "Северо-Восточный федеральный университет имени М.К.Аммосова" | Способ лечения хронического пародонтита |
-
1999
- 1999-12-02 UA UA99126560A patent/UA55454C2/ru unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2708615C1 (ru) * | 2019-10-02 | 2019-12-10 | Федеральное государственное автономное образовательное учреждение высшего образования "Северо-Восточный федеральный университет имени М.К.Аммосова" | Способ лечения хронического пародонтита |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Calişkan et al. | Allergy to sodium hypochlorite during root canal therapy: acase report | |
| AlMogbel et al. | Ozone therapy in the management and prevention of caries | |
| RU2470647C1 (ru) | Способ лечения пародонтита | |
| RU2519121C1 (ru) | Способ лечения пародонтита | |
| UA55454C2 (ru) | Способ лечения воспалительных и воспалительно-деструктивных процессов в пародонте | |
| RU2330645C2 (ru) | Способ лечения пародонтита | |
| RU2695076C1 (ru) | Способ лечения хронического генерализованного пародонтита | |
| RU2540512C1 (ru) | Способ комплексной медикаментозной обработки корневого канала зуба | |
| Henkel | The role and applicability of hyaluronidase in clinical dentistry | |
| RU2580615C1 (ru) | Способ лечения пародонтита | |
| SU1789214A1 (ru) | Cпocoб лeчehия пapoдohtиta | |
| RU2733718C1 (ru) | Композиция в форме геля для ухода за тканями полости рта | |
| RU2223088C1 (ru) | Способ лечения воспалительных и воспалительно-деструктивных заболеваний пародонта | |
| RU2806865C1 (ru) | Стоматологический гель | |
| JPS62273910A (ja) | 口腔用組成物 | |
| AL-RABADI et al. | Solcoseryl dental adhesive paste for prevention of alveolar osteitis | |
| RU2201194C2 (ru) | Лекарственная пленка для лечения воспалительных заболеваний пародонта "пиявит" | |
| RU2729428C1 (ru) | Средство для лечения пародонтита и способ лечения пародонтита | |
| RU2623052C1 (ru) | Способ профилактики осложнений у пациентов после хирургического лечения воспалительных заболеваний пародонта | |
| RU2692108C1 (ru) | Способ лечения пациентов с эрозивно-язвенными элементами поражения и/или хронического течения при заболеваниях слизистой оболочки полости рта | |
| RU2217096C1 (ru) | Способ посттравматической аутореплантации зубов | |
| Volodymyrivna et al. | UDC 615.322 HOMEOPATHIC APPLICATIONS IN DENTISTRY | |
| RU2279271C2 (ru) | Препарат для лечения стоматологических заболеваний | |
| RU2331426C1 (ru) | Способ лечения заболеваний пародонта | |
| RU2269974C2 (ru) | Способ лечения пародонтита |